文献速递乳腺乳腺X线

有个人乳腺癌史女性的数字乳腺X线与乳腺断层合成摄影性能:2007-2016年

Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016.
PubMed 文献 · Radiology · 2021-05-18

召回率8.8%,癌症检出率8.5/1000次检查,间期癌率3.6/1000次检查,活检推荐阳性预测值31.0%,敏感度70.4%,特异度98.1%。间期癌率与1996-2007年有乳腺癌史女性数据相当,且高于已发表的数字乳腺X线筛查基准;从屏-片向数字乳腺X线和断层合成过渡中,监测性能改善甚微,仍劣于筛查乳腺摄影基准。

要点

  • 监测性乳腺摄影敏感度70.4%、特异度98.1%,间期癌率3.6/1000次检查。
  • 活检推荐阳性预测值31.0%,召回率8.8%,癌症检出率8.5/1000次检查。
  • 间期癌率与1996-2007年有乳腺癌史女性数据相当,高于数字乳腺X线筛查基准。

核心结论

  • 从屏-片乳腺摄影过渡到数字乳腺X线和数字乳腺断层合成后,监测性乳腺摄影性能随时间改善甚微,仍劣于筛查乳腺摄影基准。
  • 间期癌率与1996-2007年有个人乳腺癌史女性的已发表数据相当,且高于已发表的数字乳腺X线筛查基准。

研究设计与样本

  • 观察性队列研究,5个乳腺癌监测联盟登记处提供前瞻性收集的乳腺摄影数据,并与肿瘤登记和病理结局链接。
  • 纳入美国癌症联合委员会解剖学分期0-III期原发性乳腺癌、2007-2016年接受监测性乳腺摄影的无症状女性。
  • 初次诊断时平均年龄59岁±12(标准差)。
  • 主要结局为乳腺摄影后1年内第二原发乳腺癌诊断。

诊断标准与关键数值

  • 召回率8.8%(10365/117971;95%CI:8.6%,9.0%)。
  • 癌症检出率8.5/1000次检查(998/117971;95%CI:8.0,9.0)。
  • 间期癌率3.6/1000次检查(420/117971;95%CI:3.2,3.9)。
  • 活检推荐阳性预测值31.0%(998/3220;95%CI:29.4%,32.7%)。
  • 敏感度70.4%(998/1418;95%CI:67.9%,72.7%),特异度98.1%(114331/116553;95%CI:98.0%,98.2%)。

临床应用与阅片要点

  • 在1418例第二原发乳腺癌中,998例为监测发现癌、420例为间期癌。
  • 原文结论未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Since 2007, digital mammography and digital breast tomosynthesis (DBT) replaced screen-film mammography. Whether these technologic advances have improved diagnostic performance has, to the knowledge of the authors, not yet been established. Purpose To evaluate the performance and outcomes of surveillance mammography (digital mammography and DBT) performed from 2007 to 2016 in women with a personal history of breast cancer and compare with data from 1996 to 2007 and the performance of digital mammography screening benchmarks. Materials and Methods In this observational cohort study, five Breast Cancer Surveillance Consortium registries provided prospectively collected mammography data linked with tumor registry and pathologic outcomes. This study identified asymptomatic women with American Joint Committee on Cancer anatomic stages 0-III primary breast cancer who underwent surveillance mammography from 2007 to 2016. The primary outcome was a second breast cancer diagnosis within 1 year of mammography. Performance measures included the recall rate, cancer detection rate, interval cancer rate, positive predictive value of biopsy recommendation, sensitivity, and specificity. Results Among 32 331 women who underwent 117 971 surveillance mammographic examinations (112 269 digital mammographic examinations and 5702 DBT examinations), the mean age at initial diagnosis was 59 years ± 12 (standard deviation). Of 1418 second breast cancers diagnosed, 998 were surveillance-detected cancers and 420 were interval cancers. The recall rate was 8.8% (10 365 of 117 971; 95% CI: 8.6%, 9.0%), the cancer detection rate was 8.5 per 1000 examinations (998 of 117 971; 95% CI: 8.0, 9.0), the interval cancer rate was 3.6 per 1000 examinations (420 of 117 971; 95% CI: 3.2, 3.9), the positive predictive value of biopsy recommendation was 31.0% (998 of 3220; 95% CI: 29.4%, 32.7%), the sensitivity was 70.4% (998 of 1418; 95% CI: 67.9%, 72.7%), and the specificity was 98.1% (114 331 of 116 553; 95% CI: 98.0%, 98.2%). Compared with previously published studies, interval cancer rate was comparable with rates from 1996 to 2007 in women with a personal history of breast cancer and was higher than the published digital mammography screening benchmarks. Conclusion In transitioning from screen-film to digital mammography and digital breast tomosynthesis, surveillance mammography performance demonstrated minimal improvement over time and remained inferior to the performance of screening mammography benchmarks. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Moy and Gao in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lee JM, Ichikawa LE, Wernli KJ, et al. Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016. Radiology. 2021. PMID: 34003059. doi:10.1148/radiol.2021204581

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。